Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Praecis collaborates with NCI on PPI-2458

Dec. 16, 2003

Avanir and Peregrine execute license agreement for antibody

Dec. 16, 2003

Phase I trial commences for CNTO-95

Dec. 16, 2003

Monoclonal antibody targeting CD44 induces differentiation and apoptosis in AML cells

Dec. 15, 2003

EiRx to evaluate SR Pharma's inositol phosphoglycans

Dec. 15, 2003

Novel Pin1 inhibitors designed and tested by German researchers

Dec. 15, 2003

Roche researchers prepare and test new dimeric antitumor agents

Dec. 15, 2003

Nonhypercalcemic vitamin D3 analogue HY-11 shows promising antileukemic activity

Dec. 12, 2003

Antiangiogenic PKC-beta inhibitor identified at J&J

Dec. 12, 2003

Genta completes NDA submission for Genasense for malignant melanoma

Dec. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...